3.28
1.86%
+0.06
Dopo l'orario di chiusura:
3.25
-0.03
-0.91%
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
Aquestive Therapeutics (NASDAQ:AQST) Posts Earnings Results - MarketBeat
MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Rating Increased to Strong-Buy at Leerink Partnrs - MarketBeat
MarketBeat
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Sees Large Growth in Short Interest - MarketBeat
MarketBeat
Aquestive Therapeutics (AQST) Stock Moves -0.71%: What You Should Know - Yahoo Singapore News
Yahoo Singapore News
Aquestive Therapeutics (NASDAQ:AQST) Earns “Buy” Rating from HC Wainwright - Defense World
Defense World
SVB Leerink Initiates Coverage on Aquestive Therapeutics (NASDAQ:AQST) - Defense World
Defense World
Aquestive Therapeutics (AQST) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Receives New Coverage from Analysts at SVB Leerink - MarketBeat
MarketBeat
Analysts Set Aquestive Therapeutics, Inc. (NASDAQ:AQST) Target Price at $8.00 - MarketBeat
MarketBeat
Earnings call: Aquestive Therapeutics highlights progress and outlook for 2024 - Investing.com South Africa
Investing.com South Africa
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Aquestive Therapeutics' (AQST) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
MarketBeat
Aquestive Therapeutics First Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Simply Wall St
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference - Yahoo Finance
Yahoo Finance
Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are ... - Yahoo Finance
Yahoo Finance
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference - Investing.com South Africa
Investing.com South Africa
Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: What You Should Know - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
Best Momentum Stocks to Buy for May 9th - Yahoo Canada Shine On
Yahoo Canada Shine On
Aquestive Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation (NASDAQ:AQST) - Seeking Alpha
Seeking Alpha
Aquestive Therapeutics: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Aquestive Therapeutics earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa
Investing.com South Africa
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research
Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance UK
Yahoo Finance UK
Aquestive Therapeutics: Q1 Earnings Snapshot - Press of Atlantic City
Press of Atlantic City
Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - 07.05.2024 - wallstreet:online
wallstreet:online
Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance UK
Yahoo Finance UK
Down -31.17% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround - Yahoo Singapore News
Yahoo Singapore News
Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last? - Yahoo Finance UK
Yahoo Finance UK
Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last? - Yahoo Finance Australia
Yahoo Finance Australia
Aquestive Therapeutics (NASDAQ:AQST) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
Down -31.17% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround - Yahoo Movies UK
Yahoo Movies UK
Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why - Yahoo New Zealand News
Yahoo New Zealand News
Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks Investment Research
Aquestive Therapeutics (AQST) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
MarketBeat
Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for - Zacks Investment Research
Zacks Investment Research
Aquestive stock falls amid Libervant approval, Anaphylm update (NASDAQ:AQST) - Seeking Alpha
Seeking Alpha
Aquestive wins FDA nod for seizure drug Libervant (NASDAQ:AQST) - Seeking Alpha
Seeking Alpha
Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and ... - Yahoo Finance
Yahoo Finance
FDA Action Alert: ImmunityBio, Aquestive, XOMA and More - BioSpace
BioSpace
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring - Markets Insider
Markets Insider
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
GlobeNewswire Inc.
Aquestive Therapeutics (NASDAQ:AQST) Now Covered by Analysts at Piper Sandler - Defense World
Defense World
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual ... - Yahoo Finance
Yahoo Finance
Aquestive Stock: Positive Phase III Data Unlocks Additional Catalysts For 2024 (AQST) - Seeking Alpha
Seeking Alpha
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
Benzinga
Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note
Zacks Investment Research
Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Yahoo Finance
Capitalizzazione:
|
Volume (24 ore):